Current liabilities - Warrants financial liability | Note 6. Current liabilities - Warrants financial liability June 30, 2024 December 31, $ $ Unaudited Warrants at fair value 1,555,632 1,075,808 The Company accounts for warrants issued to investors in conjunction with IFRS 9 “Financial Instruments” accounting standards issued by IASB. (a) On August 25, 2022, the Company completed its U.S. listing on the Nasdaq via the issuance of 3,220,338 American Depository Shares (“ADSs”) and the accompanying 3,220,338 tradable pre-funded warrants for a total consideration of $13,299,996. Each ADS represents 275 ordinary shares, no In addition, on August 25, 2022, in connection with the U.S listing, the Company granted a total 161,017 representative warrants each exercised to one ADS at an exercise price of $5.16. The representative warrants have 5-year term, and they can be exercised any time before their expiry date August 25, 2027. The representative warrants may be exercised on a cashless basis if there is no effective registration statement registering the ADSs underlying the warrants. The tradable pre-funded warrant and representative warrant are referred herein together as “August 2022 Warrants”. The August 2022 Warrants represent financial liabilities at fair value through profit or loss. On June 30, 2023, the Company reassessed the valuation methodology applied to the valuation of the August 2022 Warrants, in conjunction with an independent valuation from a third party. The August 2022 Warrants are trading on Nasdaq and based on current market activity, it was deemed to be in an active market. The directors believe the quoted share price of the MOBBW security trading on the Nasdaq represents a more accurate valuation of the August 2022 Warrants based on the guidance of IFRS 13 Fair Value Measurement The following assumptions were based on observable market conditions that existed at December 31, 2023 and of June 30, 2024: Assumption At December 31, 2023 At June 30, 2024 Value methodology Level 1 Level 1 Level 1 Level 1 Exercise price $ 5.0 $ 5.16 $ 5.0 $ 5.16 Share price $ 0.367 $ 0.367 $ 0.130 $ 0.130 Fair value per warrant $ 0.367 $ 0.367 $ 0.130 $ 0.130 For the half-year ended June 30, 2024, the Company recorded fair value gain, net of translation adjustments of $694,732 under the as a result of the change in the fair (b) On January 30, 2024, the Company completed a registered direct offering via the issuance of 486,871 ADSs at an offering price of $1.55 per ADS and 1,416,354 pre-funded warrants at an offering price of $1.5499 for a total consideration of $2,949,857. One pre-funded warrant is exercisable to one ADS upon payment of the remain $0.0001 per warrant. During April 2024, 520,078 pre-funded warrants were exercised into 520,078 ADS for a total of $52, and 520,078 pre-funded warrants were exercised into 519,656 ADS on a cashless basis. In addition, on January 30, 2024, in a concurrent private placement, the Company issued to the investors in the registered direct offering warrants to purchase up to an aggregate of 1,903,225 ADS at an exercise price of $1.55 per ADS. The warrants have 5-year term, and they can be exercised any time before expiry date January 30, 2029. The warrants may be exercised on a cashless basis if there is no effective registration statement registering the ADSs underlying the warrants. In addition, on January 30, 2024, in connection with the registered direct offering, the Company granted a total 95,161 placement agent warrants each exercisable to one ADS at an exercise price of $1.55. The placement agent warrants have 5-year term, and they can be exercised any time before expiry date January 30, 2029. The placement agent warrants may be exercised on a cashless basis if there is no effective registration statement registering the ADSs underlying the warrants. The pre-funded warrant, private placement warrants, and placement agent warrant are referred herein together as “January 2024 Warrants”. The January 2024 Warrants represent financial liabilities at fair value through profit or loss. The following assumptions were based on observable market conditions that existed at issued date and of June 30, 2024: At issue date At June 30, 2024 Assumption Value methodology Level 2 Level 2 Level 2 Level 2 Historical volatility 86 % 86 % 86 % 86 % Exercise price $ 0.000 $ 1.550 $ 0.000 $ 1.550 Share price $ 1.270 $ 1.270 $ 0.965 $ 0.965 Risk-free interest rate 4.3 % 4.3 % 4.3 % 4.3 % Dividend yield 0 % 0 % 0 % 0 % Fair value per warrant $ 1.270 $ 0.574 $ 0.965 $ 0.406 For the half-year ended June 30, 2024, the Company recorded fair value gain, net of translation adjustments of $597,639 under the unaudited interim condensed consolidated statement of profit or loss and other comprehensive income as a result of the change in the fair value of January 2024 Warrants. A summary of changes in August 2022 Warrants and January 2024 Warrants issued by the Company during the year ended June 30, 2024, is as follows: Fair value measurements using input type Level 1 Level 2 Level 3 Balance as of December 31, 2023 $ 1,075,808 $ - - Warrants issued during the period 2,945,971 Transfer upon exercise of warrants (1,173,776 ) Fair value gain recognized in unaudited interim condensed consolidated statement of profit or loss and other comprehensive income (694,732 ) (597,639 ) - Warrant liability as of June 30, 2024 $ 381,076 $ 1,174,556 - |